Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Low · SciRah

Researcher profile · Semantic Scholar

L. Low

Share profile

L. Low — researcher profile on SciRah

h-index: 5
Works: 9
Citations: 273

Most-cited papers

DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer
L. Low, A. Mander, Katy J. McCann, D. Dearnaley +4 more
2009Human Gene Therapy183 citations
Semantic Scholar
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC).
Wai-Ming Tai, W. Yong, C. Lim, L. Low +12 more
2016Annals of Oncology40 citations Open access
Semantic Scholar
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC).
Wai-Ming Tai, W. Yong, C. Lim, L. Low +12 more
2018Annals of Oncology20 citations Open access
Semantic Scholar
Fit for purpose? A case study: validation of immunological endpoint assays for the detection of cellular and humoral responses to anti-tumour DNA fusion vaccines
A. Mander, F. Chowdhury, L. Low, C. Ottensmeier
2009Cancer Immunology and Immunotherapy19 citations Open access
Semantic Scholar
A phase I/II study of AZD6244 in combination with sorafenib in advanced hepatocellular carcinoma.
S. Choo, Sing-Ng Quan, W. Chen, C. Tham +8 more
20128 citations
Semantic Scholar
Clinical and immunological responses to a DNA fusion vaccine in patients with carcinoembryonic antigen-expressing tumors: A Cancer Research UK phase I/II study.
C. Ottensmeier, A. Mander, Katy J. McCann, L. Low +6 more
20103 citations
Semantic Scholar
The North Trent experience of the use of first line pembrolizumab in stage IIIB/IV non-small cell lung cancer
R. Elmushraf, H. Clinch, A. Salawu, P. Fisher +8 more
2019Lung Cancer0 citations
Semantic Scholar
The North Trent experience of administering pembrolizumab to previously treated patients with advanced non-small cell lung cancer
L. Low, A. Salawu, E. Bates, R. Young +6 more
20180 citations
Semantic Scholar
182P Real world anti-PD-L1 treatment (tx) outcomes in a multinational European non-small cell lung cancer (NSCLC) cohort with focus on toxicity (tox) and brain metastases (BM): Preliminary data from an EORTC young investigators lung cancer group collaborative analysis
R. Tassi, F. Taylor, S. Canova, L. Low +6 more
20180 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Mander×3
Invite
A. Mander — researcher profile on SciRah
C. Ottensmeier×3
Invite
C. Ottensmeier — researcher profile on SciRah
C. Tham×3
Invite
C. Tham — researcher profile on SciRah
T. Koh×3
Invite
T. Koh — researcher profile on SciRah

×3

Invite

C. Thng — researcher profile on SciRah

Invite

H. Toh — researcher profile on SciRah

Invite

S. Choo — researcher profile on SciRah

Katy J. McCann×2

Invite

Katy J. McCann — researcher profile on SciRah

F. Stevenson×2

Invite

F. Stevenson — researcher profile on SciRah

Wai-Ming Tai×2

Invite

Wai-Ming Tai — researcher profile on SciRah

Invite

C. Lim — researcher profile on SciRah

Invite

Q. Ng — researcher profile on SciRah